Blog | Veristat Insightful Perspectives

Contact Veristat Now


Request A Proposal

Contact Us

Be a Trusted Friend

January 5, 2017

For anyone who follows this blog with even moderate consistency, it is probably clear that Veristat is a growing organization.  It is hopefully just as apparent that we are a group who tremendously values and fiercely protects our culture. 

Read More

This Holiday Season, Let’s Fight Rare Cancers Together!

December 16, 2016

This Holiday Season, Veristat is continuing its tradition of participating in the Movement to Beat Rare Cancers!

On behalf of all of our clients, Veristat has made a $12,500 donation to one of the many organizations that we supported this year and will support in 2017, Cycle for Survival.

Read More

How Do You Make Informed Decisions about Implementing Adaptive Designs?

December 15, 2016

Read more about this and the discussions that you missed at the MassBio Forum on Adaptive Designs in Clinical Research that took place last month.

Read More

Veristat Pauses to Celebrate its Dedication to Making Lives Longer and Healthier

November 23, 2016

Just last week, in the midst of the daily chaos of building new clinical trial databases, working on impending regulatory submissions, holding project team meetings, and programing tables figures & listings, Veristat paused its operations for one day in order to reflect upon and celebrate its contributions to drug development.

Read More

How to Select & Execute a Biomarker-Driven Clinical Trial Designs

October 4, 2016

At the 2016 Duke Industry Statistics Symposium, Dr. Robin Bliss, in collaboration with Dr. Jing Wang of Gilead Sciences, lead a discussion on “Biomarker-Driven Clinical Trial Designs for Precision Medicine.”  Dr. Bliss highlighted two Adaptive Enrichment Clinical Trials performed by Veristat as case studies for how to select and execute an enrichment clinical trial design.

Read More

Veristat Acknowledged for its Rapid Growth on the Inc. 5000 List of America’s Fastest-Growing Private Companies

August 17, 2016

Veristat Continues To Be Recognized for Its Positive Impact & Company Growth

Today we announced that we have been recognized once again by Inc. Magazine as one of America’s fastest-growing private companies. Veristat debuted on the list in 2015.  

Read More

What Are the Major/Common Types of Adaptive Designs Used in Clinical Trials Today?

August 5, 2016

An adaptive design is a clinical trial design that allows adaptations or modifications to aspects of the trial after its initiation without undermining the validity and integrity of the trial. An adaptive design consists of multiple stages. At each stage, data analyses are conducted and adaptations take place based on updated information to maximize the probability of success of a trial.

Read More

Biostatisticians: 3 Tips to Knowing When Adaptive Design Is Right for Your Clinical Trial

July 14, 2016

If you're reading this as a biostatistician or clinical trial professional, you know that the pharmaceutical industry is shifting from classical to adaptive clinical trial design in an effort to reduce NDA failure rate, lower the cost of research and development, and expedite the precision medicine movement. As a member of the Talent & Culture team at Veristat (a CRO), I spend a great deal of time speaking with people like yourself, many of whom are potential candidates excited about the opportunity to work at a company where they may get exposure to an adaptive design trial. Realizing the consistency across these conversations, I have begun wondering if their interest in adaptive designs is a result of it being a current trends, or if it is because adaptive design truly offers increased efficiencies. As a result, I have spent some time research when adaptive design might not be right for a clinical trial and have found two articles that discuss when it is appropriate to use them.

Read More

What You Missed at the Event of the Year | #DIA2016

July 8, 2016

Veristat joined over 6500+ life sciences professionals at the Drug Information Associations (DIA) Annual Meeting  that recently took place in Philadelphia, PA. The conference featured over 175 topics in 25 tracks covering the latest innovations, trends, challenges, and solutions faced by drug developers today. The hottest topics of the meeting were related directly to recent industry trends and events, including increased patient safety, the Zika outbreak, harnessing data to find cures, and many more.

Read More

Fueled by Growth, Veristat Continues Geographic Expansion

June 27, 2016

Veristat announced today that it is continuing its accelerated growth and geographic expansion with the opening of an office in Raleigh-Durham, North Carolina. In addition to this newly planned North Carolina office, Veristat has additional North American-based offices in Southborough, MA, Cambridge, MA, San Bruno, CA, Montreal, Canada, and its European office in Glasgow, UK. The new office, scheduled to open in the fall of 2016, will support the company’s accelerated growth by engaging an experienced talent pool and providing local support to Veristat’s clients in the area.

Read More